Invention Grant
- Patent Title: Oxprenolol compositions for treating cancer
-
Application No.: US14776020Application Date: 2014-03-14
-
Publication No.: US10398658B2Publication Date: 2019-09-03
- Inventor: Andrew J.S. Coats , Stefan Anker , Jochen Springer
- Applicant: ACTIMED THERAPEUTICS LIMITED
- Applicant Address: GB Ascot Berkashire
- Assignee: Actimed Therapeutics Limited
- Current Assignee: Actimed Therapeutics Limited
- Current Assignee Address: GB Ascot Berkashire
- Agency: MH2 Technology Law Group, LLP
- International Application: PCT/AU2014/000266 WO 20140314
- International Announcement: WO2014/138806 WO 20140918
- Main IPC: A61K31/138
- IPC: A61K31/138
Abstract:
The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients.
Public/Granted literature
- US20160022612A1 OXPRENOLOL COMPOSITIONS FOR TREATING CANCER Public/Granted day:2016-01-28
Information query
IPC分类:
